endocrinology
Medicines

No bladder cancer link to glitazones

Previous studies had found a link, leading to the withdrawal of pioglitazone in France and Germany. However in a bid to overcome the limitations of the previous studies the authors measured the effect of exposure to pioglitazone on bladder cancer risk across several cohorts. No evidence was seen of a link between pioglitazone or rosiglitazone ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic